New-born screening of metabolites with liquid chromatography-mass spectrometry and gas chromatography–mass spectrometry: a metabolic and molecular signatures methyl malonic aciduria with combined oxidative phosphorylation deficiency-10: a rare case report

Authors

  • Samu Subramaniam Department of Biochemistry, Regenix Super Specialty Laboratories Private Ltd., Chennai, Tamil Nadu, India
  • Arasar Seeralar A. T. Department of Paediatrics, ACS Medical College, Chennai, Tamil Nadu, India
  • Shyama Subramaniam Consultant, Lab Service, Apollo Hospitals, Chennai, Tamil Nadu, India
  • Subhasree Ramarathinam Chelladurai Scientist, Tamil Nadu Veterinary and Animal Sciences University (TANUVAS), Translational Research Platform for Veterinary Biologicals (TRPVB)- A DBT initiative, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20231854

Keywords:

Newborn screening, Tandem mass spectrometry, Liquid chromatography-mass spectrometry, Gas-chromatography-mass spectrometry, Clinical exome sequencing

Abstract

An uncommon autosomal recessive organic acid disease is malonic aciduria. This disease may be easily identified and included in the NBS programmes by means of the widespread use of tandem mass spectrometry’s in the study of the amino acid/acylcarnitine profile using dried blood spots (DBS) for newborn screening. In Tamil Nadu, we reported the first screened and diagnosed with malonic aciduria by newborn screening (NBS) in early neonatal period. The patient possesses a malonyl-CoA decarboxylase genetic variation not previously described. This disease should be distinguished from a related malonic and methylmalonic aciduria problem. Malonic aciduria's clinical phenomenology varies and pathogenesis is not completely known. The proper treatment regimen, nutritional therapy or frequent follow-up to these individuals are not guided or recommended. The majority of current treatment data is based on a single research or case report.

References

Medplus. Fact sheet: Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/condition/ malonyl-coa-decarboxylasedeficiency. Accessed on 15 December 2023.

An JH, Kim YS. A gene cluster encoding malonyl-CoA decarboxylase (MatA), malonyl-CoA synthetase (MatB) and a putative dicarboxylate carrier protein (MatC) in Rhizobium trifolii clining, sequencing, and expression of the enzymes in Escherichia coli. Eur J Biochem. 1998;257(2):395-402.

McGarry JD, Brown NF. The mitochondrial carnitine plamitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997;244(1):1-14.

Chandler RJ, Venditti CP. Genetic and genomic systems to study methylmalonic acidemia. Mol Genet Metab. 2005;86(1-2):34-43.

Pourfarzam M, Zadhoush F. Newborn screening for inherited metabolic disorders; news and views. J Res Med Sci. 2013;18(9):801-8.

Manoli I, Sloan JL, Venditti CP. Isolated methylmalonic acidemia. In: Adam MP, Mirzaa GM, Pagon RA, eds. Seattle (WA): University of Washington: GeneReviews; 1993.

Velden MG, Diekman EF, Jans JJ. Differences between acylcarnitine profiles in plasma and bloodspots. Mol Genet Metab. 2013;110(1-2):116-21.

Lim MD. Dried blood spots for global health diagnostics and surveillance: opportunities and challenges. Am J Trop Med Hyg. 2018;99(2):256-65.

Zhou X, Cui Y, Han J. Methylmalonic acidemia: Current status and research priorities. Intractable Rare Dis Res. 2018;7(2):73-8.

Okroglic S, Widmann CN, Urbach H, Scheltens P, Heneka MT. Clinical symptoms and risk factors in cerebral microangiopathy patients. PLoS One. 2013;8(2):53455.

Dahash BA, Sankararaman S. Carnitine deficiency. Treasure Island (FL): StatPearls Publishing; 2023.

Asadi M, Rahimlou M, Shishehbor F, Mansoori A. The effect of l-carnitine supplementation on lipid profile and glycaemic control in adults with cardiovascular risk factors: A systematic review and meta-analysis of randomized controlled clinical trials. Clin Nutr. 2020;39(1):110-22.

Park KC, Krywawych S, Richard E, Desviat LR, Swietach P. Cardiac complications of propionic and other inherited organic acidemias. Front Cardiovasc Med. 2020;7:617451.

Hwang N, Jang JH, Cho EH, Choi R, Choi SJ, Park HD. Prenatal diagnosis of combined methylmalonic acidemia and homocystinuria cobalamin C type using clinical exome sequencing and targeted gene analysis. Mol Genet Genomic Med. 2021;9(11):1838.

Chu TH, Chien YH, Lin HY. Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups. Orphanet J Rare Dis. 2019;14(1):73.

Haijes HA, Molema F, Langeveld M. Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening? J Inherit Metab Dis. 2020;43(3):424-37.

Pillai NR, Stroup BM, Poliner A. Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review. Mol Genet Metab. 2019;128(4):431-43.

Pajares S, Arranz JA, Ormazabal A. Implementation of second-tier tests in newborn screening for the detection of vitamin B12 related acquired and genetic disorders: results on 258,637 newborns. Orphanet J Rare Dis. 2021;16(1):195.

Downloads

Published

2023-06-27

Issue

Section

Case Reports